Type6 Therapeutics
unknown
unknown
Stage
1
Investors
About
Type6 Therapeutics applies computational biology to identify and develop therapies that target disease-driving kinases. The company focuses on kinase-targeted drug discovery using in silico approaches.
Explore Type6 Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.